glp-1 and pancreas receptor biology: structure, signaling, distribution GLP-1 | Summary

Note: Anti-Obesity GLP-1s Wegovy and Zepbound, Anti-Diabetes GLP-1s Ozempic and Mounjaro Source: IQVIA MAAS Patient Behavior Library Tool

Our Spring/Summer Transformation Special is in its final weeks, and there has never been a better time to finish your look

This blog aims to provide clarity by discussing what GLP-1 agonists are, their benefits, their role compared to bariatric surgery, and how a combined approach might provide the best outcomes

For those with HSA or FSA accounts, PlexusDx qualifies as an eligible health expense, adding tax-advantaged savings on top of the already-reduced pricing

In a phase 2 study, patients with obesity on the highest dose (12 mg) lost an average of about 24% of their body weight in 48 weeks